Gland Pharma Ltd. (GLAND): Gland Pharma Share Price Near 52-Week High After 3.38% Gain

Gland Pharma Share Price is Rs 2,993.30, up 3.38% today, and trading close to its 52-week high with a market capitalisation of Rs 48,107.26 Cr. The move keeps Gland Pharma Ltd. (GLAND) in focus across Gland Pharma Share Price Today searches and Gland Pharma Stock News coverage.

Gland Pharma Share Price is Rs 2,993.30 as of 29 September 2026 at 12:52 PM IST, up Rs 97.80 or 3.38% from the previous close of Rs 2,895.50. The stock is trading near its 52-week high and the company’s market capitalisation stands at Rs 48,107.26 Cr. For investors tracking Gland Pharma Share Price Today, the latest move places the stock in the centre of Gland Pharma Stock News and broader Stock Market Today attention within the healthcare space.

Gland Pharma Share Price Today: Price Action Analysis

The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. What is clear is that Gland Pharma Share Price is holding near a yearly high after opening at Rs 2,909.60 and moving between Rs 2,909.60 and Rs 3,015.90 during the trading window. That price action is enough to keep Gland Pharma Share Price Today visible in Share Market Today screens, especially for readers looking at 52 Week High Stocks and Gland Pharma Share Price Update coverage.

From a news perspective, this is a Gland Pharma Share Price event first and foremost. The stock is trading above the previous close, and the latest level places it close to the 52-week peak without changing that factual framing into a record-high narrative. Univest tracks this kind of move because it often becomes a focal point for Gland Pharma Stock Analysis, even when the latest data does not identify why the move occurred.

Metric	Value
Current Price	Rs 2,993.3
Previous Close	Rs 2,895.5
Today's Move	+Rs 97.8 (+3.38%)
Open	Rs 2,909.6
High	Rs 3,015.9
Low	Rs 2,909.6
Market Capitalisation	Rs 48,107.26 crore

Gland Pharma Ltd. (GLAND) traded at Rs 2,993.3 versus the previous close of Rs 2,895.5, a rise of 3.38%. The stock opened at Rs 2,909.6, reached a high of Rs 3,015.9 and touched a low of Rs 2,909.6.

Gland Pharma Share Price Today shows a clear intraday uplift from the previous close, with the stock at Rs 2,993.30 after starting the day at Rs 2,909.60 and touching a high of Rs 3,015.90. The day low was Rs 2,909.60, which means the stock spent the recorded range above the opening level and well above the prior close.

For readers following Gland Pharma Share Price, the key factual comparison is straightforward: Rs 2,993.30 versus Rs 2,895.50. That difference of Rs 97.80 equals 3.38%, which is why Gland Pharma Share Price Today continues to appear in Gland Pharma Share News and Gland Pharma Latest News feeds. The stock is also near its 52-week high, so the move has been strong enough to keep it among Stocks in News and 52 Week High Stocks on the Indian Stock Market watchlist.

Because the stock is near its yearly high, today’s Gland Pharma Share Price movement matters less as a standalone number and more as a continuation of price action around the upper part of the recent range. Univest highlights this sort of Gland Pharma Share Price Update so readers can see what the market is doing without assuming a reason that has not been verified.

The same reading also fits the broader Share Market Today theme: Gland Pharma Share Price Today is not just higher, it is higher while sitting close to a 52-week high. That combination is why the stock is appearing in Market Movers screens and why Gland Pharma Stock News is drawing search interest today.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 48,107.26 crore
P/E Ratio	42.33x
P/B Ratio	4.5x
ROE	10.56%
ROCE	14.96%
EPS	Rs 68.41
Book Value Per Share	Rs 644.16
Dividend Yield	0.69%

Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 42.33x, P/B 4.5x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.

Gland Pharma Ltd. has a market capitalisation of Rs 48107.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.33x, P/B at 4.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.69%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.91x, median ROE of 11.74%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	42.33x
Benchmark Median P/E	27.91x
Benchmark Average P/E	41.61x
Benchmark P/E Range	0x to 707.31x
Company P/B Ratio	4.5x
Benchmark Median P/B	2.83x
Company ROE	10.56%
Benchmark Median ROE	11.74%
Company ROCE	14.96%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 48,107.26 crore
Benchmark Median Market Cap	Rs 782.41 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.33x, which is above the benchmark median of 27.91x, a difference of +51.67%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.74%, a difference of -10.05%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.46%, a difference of +11.14%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Glaxosmithkline Pharmaceuticals Ltd.	GLAXO	47,719.14	45.96	19.48	48.76	66.79
Anthem Biosciences Ltd.	ANTHEM	49,272.07	83.28	15.33	21.98	29.62
Ipca Laboratories Ltd.	IPCALAB	49,967.05	37.19	5.74	15.88	19.41
Ajanta Pharma Ltd.	AJANTPHARM	44,344.21	38.87	9.08	25.42	32.67
Abbott India Ltd.	ABBOTINDIA	57,236.69	35.21	10.99	34.67	46.72

Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.33x compared with the displayed peer median of 38.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.56% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 48,107.26 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Gland Pharma

• Gland Pharma Share Price Today is Rs 2,993.30, up 3.38% from the previous close.
• The stock is trading near its 52-week high, which keeps Gland Pharma Share Price in the 52 Week High Stocks list.
• Market capitalisation stands at Rs 48,107.26 Cr, which is central to Gland Pharma Stock Analysis.
• The P/E ratio of 42.33 and P/B ratio of 4.5 are key points in Gland Pharma Fundamental Analysis.
• Revenue at Rs 18,002.71 Cr in Jun 2026 and net profit of Rs 3,169.59 Cr in Jun 2026 give context to Gland Pharma Stock News.

About Gland Pharma

Gland Pharma Share Price relates to Gland Pharma Ltd., a company classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. Its market capitalisation, valuation ratios, earnings per share and book value are the main company-level figures available here, and they frame the Gland Pharma Share Price Today discussion. Univest uses this company profile alongside Gland Pharma Stock News, Gland Pharma Latest News and Gland Pharma Share Price Live coverage to keep the stock view focused on verified market and financial data.

Frequently Asked Questions

Why is Gland Pharma Share Price in focus today?

Ans. Gland Pharma Share Price is in focus because it is trading at Rs 2,993.30, up 3.38% from the previous close, and it is also near its 52-week high. That combination is drawing Gland Pharma Stock News attention.

What is Gland Pharma Share Price Today?

Ans. Gland Pharma Share Price Today is Rs 2,993.30 as of 29 September 2026 at 12:52 PM IST. The stock moved from a previous close of Rs 2,895.50 and stayed within a range of Rs 2,909.60 to Rs 3,015.90.

How much did Gland Pharma Share Price move today?

Ans. Gland Pharma Share Price rose by Rs 97.80, or 3.38%, versus the previous close. That is the latest verified move and it places Gland Pharma Share Price Today close to the yearly high.

Is Gland Pharma trading near a 52-week high?

Ans. Yes. Gland Pharma Share Price is trading near its 52-week high. The stock has not been described as breaking a record here; it is simply positioned close to that level in the latest market update.

What do the valuation ratios show for Gland Pharma Share Price?

Ans. Gland Pharma Share Price carries a P/E of 42.33 and a P/B of 4.5. Both ratios sit above the same-industry median, which makes Gland Pharma Fundamental Analysis an important part of the story.

What profitability ratios should investors note?

Ans. Gland Pharma reports ROE of 10.56% and ROCE of 14.96%. EPS stands at Rs 68.41 and book value is Rs 644.16, giving Gland Pharma Share Price Today some basic per-share context.

How does Gland Pharma compare with peers?

Ans. Compared with peers such as Alkem Laboratories, Abbott India and Ajanta Pharma, Gland Pharma Share Price has a higher valuation multiple than some peers and lower return ratios than others. Peer comparison is mixed, not one-sided.

How can investors track Gland Pharma Share Price on Univest?

Ans. Investors can track Gland Pharma Share Price on Univest for live price updates, 52-week levels, valuation ratios, financial results, and Gland Pharma Stock News. Univest keeps the same stock view together in one place.

Track Gland Pharma Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Gland Pharma Share Price on Univest for live share price updates, 52-week levels, market capitalisation, valuation ratios, revenue and profit snapshots, and Gland Pharma Share News. Univest also makes it easier to follow Gland Pharma Share Price Today alongside Gland Pharma Stock Analysis and Gland Pharma Fundamental Analysis in one place.